Literature DB >> 9117181

Prolonged effects of 3 week therapy in a spa resort on lumbar spine, knee and hip osteoarthritis: follow-up after 6 months. A randomized controlled trial.

M Nguyen1, M Revel, M Dougados.   

Abstract

Spa therapy is frequently used in daily rheumatological practice, but its benefit remains to be evaluated. A prospective randomized controlled study was conducted in 1993 in patients with osteoarthritis of the hip, knee or lumbar spine. Treatment was either spa therapy at Vichy (France) of 3 weeks duration (spa group) or usual therapy (control group). Assessment criteria were pain (visual analogue scale), functional impairment (Lequesne's index for hip or knee disease, Main and Waddell's for lumbar spinal diseases), quality of life index [revised Arthritis Impact Measurement Scale (AIMS2)], and analgesic and/or non-steroidal anti-inflammatory drug (NSAID) consumption. Patients were included by randomization into one of the two arms (spa or control) and assessment criteria were collected before spa therapy or the control period, and 3 and 24 weeks thereafter. A total of 188 patients (lumbar spine 95, knee 64, hip 29) were included in the study (spa group 91, control group 97). Changes in the assessment criteria after a 6 month follow-up period showed improvement in terms of pain, functional impairment and quality of life, with a reduced intake of symptomatic drugs (NSAID and analgesic drugs) in the spa group. This study suggests that spa therapy of 3 weeks duration has a prolonged, beneficial, symptomatic effect in osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9117181     DOI: 10.1093/rheumatology/36.1.77

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  30 in total

1.  A brief history of spa therapy.

Authors:  A van Tubergen; S van der Linden
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 2.  Hydrotherapy, balneotherapy, and spa treatment in pain management.

Authors:  Tamás Bender; Zeki Karagülle; Géza P Bálint; Christoph Gutenbrunner; Péter V Bálint; Shaul Sukenik
Journal:  Rheumatol Int       Date:  2004-07-15       Impact factor: 2.631

3.  Balneotherapy for chronic low back pain: a randomized, controlled study.

Authors:  Nur Kesiktas; Sinem Karakas; Kerem Gun; Nuran Gun; Sadiye Murat; Murat Uludag
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 4.  [Physical therapy of osteoarthritis].

Authors:  B Kladny
Journal:  Z Rheumatol       Date:  2005-10       Impact factor: 1.372

Review 5.  Short- and long-term therapeutic effects of thermal mineral waters in knee osteoarthritis: a systematic review of randomized controlled trials.

Authors:  Taoufik Harzy; Najoua Ghani; Nessrine Akasbi; Wafaa Bono; Chakib Nejjari
Journal:  Clin Rheumatol       Date:  2009-02-19       Impact factor: 2.980

6.  Balneotherapy in medicine: A review.

Authors:  Ali Nasermoaddeli; Sadanobu Kagamimori
Journal:  Environ Health Prev Med       Date:  2005-07       Impact factor: 3.674

7.  Efficacy of balneotherapy on pain, function and quality of life in patients with osteoarthritis of the knee.

Authors:  Antonella Fioravanti; Chiara Giannitti; Barbara Bellisai; Francesca Iacoponi; Mauro Galeazzi
Journal:  Int J Biometeorol       Date:  2011-05-15       Impact factor: 3.787

8.  Effects of balneotherapy and spa therapy on quality of life of patients with knee osteoarthritis: a systematic review and meta-analysis.

Authors:  Michele Antonelli; Davide Donelli; Antonella Fioravanti
Journal:  Rheumatol Int       Date:  2018-06-12       Impact factor: 2.631

9.  Real-life effectiveness of spa therapy in rheumatic and musculoskeletal diseases: a retrospective study of 819 patients.

Authors:  Mine Karagülle; Sinan Kardeş; Müfit Zeki Karagülle
Journal:  Int J Biometeorol       Date:  2017-05-30       Impact factor: 3.787

10.  Short- and long-term effects of mud-bath treatment on hand osteoarthritis: a randomized clinical trial.

Authors:  Antonella Fioravanti; Sara Tenti; Chiara Giannitti; Nicola Angelo Fortunati; Mauro Galeazzi
Journal:  Int J Biometeorol       Date:  2013-01-14       Impact factor: 3.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.